





Dairy foods and health: an umbrella review of observational studies 1	
 2	
Justyna Godos1,2, Maria Tieri3, Francesca Ghelfi2,3, Lucilla Titta3, Stefano Marventano4, Alessandra 3	
Lafranconi5,6, Angelo Gambera7, Elena Alonzo8, Salvatore Sciacca9, Silvio Buscemi10, Sumantra 4	
Ray2,11, Daniele Del Rio2,12,13, Fabio Galvano1*, Giuseppe Grosso1,2* 5	
 6	
1 Department of Biomedical and Biotechnological Sciences, University of Catania, Catania, Italy; 7	
2 NNEdPro Global Centre for Nutrition and Health, St John’s Innovation Centre, Cambridge, 8	
United Kingdom, Wolfson College at the University of Cambridge, United Kingdom, Nutrition 9	
Innovation Centre for Food and Health at Ulster University, United Kingdom; 10	
3 SmartFood Program, Department of Experimental Oncology, IEO, European Institute of 11	
Oncology IRCCS, Milan, Italy; 12	
4 Rimini Women’s Health, Childhood and Adolescent Department, AUSL Romagna, Rimini, Italy; 13	
5 University of Milano – Biccoca, Milan, Italy; 14	
6 Care and Public Health Research Institute, Maastricht University, Maastricht, The Netherlands; 15	
7 Azienda Ospedaliero-Universitaria Policlinico-Vittorio Emanuele, Catania, Italy; 16	
8 Food and Nutrition Security and Public Health Service, ASP Catania, Catania, Italy; 17	
9 Integrated Cancer Registry of Catania-Messina-Siracusa-Enna, Azienda Ospedaliero-18	
Universitaria Policlinico-Vittorio Emanuele, Catania, Italy; 19	
10 Biomedical Department of Internal and Specialist Medicine (DIBIMIS), University of Palermo, 20	
Palermo, Italy; 21	
11 Medical Research Council (MRC) Human Nutrition Research Unit, Cambridge, United 22	
Kingdom; 23	
12 The Laboratory of Phytochemicals in Physiology, Department of Food and Drug, University of 24	
Parma, Parma, Italy; 25	
13 The Laboratory of Phytochemicals in Physiology, Department of Veterinary Science, University 26	
of Parma, Parma, Italy. 27	
*Equal contribution 28	
 29	
Corresponding author: Giuseppe Grosso, Department of Biomedical and Biotechnological Sciences, 30	
University of Catania, Via Santa Sofia 97, 95123 Catania, Italy (email: 31	






Dairy foods and health: an umbrella review of observational studies 33	
 34	
Keywords: dairy products; milk; cheese; yogurt; butter; evidence; prospective; cohort; meta-35	
analysis; umbrella review 36	
 37	
Abstract 38	
Evidence on consumption of dairy foods and human health is mixed. This study aimed to 39	
summarize the level of evidence of dairy consumption on various health outcomes. A systematic 40	
search for meta-analyses was performed: study design, dose-response relationship, heterogeneity 41	
and agreement of results over time, and identification of potential confounding factors were 42	
considered to assess the level of evidence. Convincing and probable evidence of decreased risk of 43	
colorectal cancer, hypertension, and cardiovascular disease, elevated blood pressure and fatal 44	
stroke, respectively, was found for total dairy consumption; possible decreased risk of breast 45	
cancer, metabolic syndrome, stroke, and type-2 diabetes, and increased risk of prostate cancer and 46	
Parkinson’s disease was also found. Similar, yet not entirely consistent evidence for individual 47	
dairy products was reported. Among potential confounding factors, geographical localization and 48	
fat content of dairy have been detected. In conclusions, dairy may be part of a healthy diet; 49	
however, additional studies exploring confounding factors are needed to ascertain the potential 50	







Over the last decades, the role of dairy foods in relation to chronic-degenerative non-communicable 53	
diseases, including cardiovascular disease (CVD) (Huth and Park 2012), metabolic disorders 54	
(Abedini et al. 2015, Rice Bradley 2018), bone health (Giganti et al. 2014), and various types of 55	
cancer (Abid et al. 2014), has been investigated in several epidemiological studies and led to the 56	
hypothesis that they might have a positive impact on health (Pereira 2014). However, concerns 57	
regarding their potential harms have been often raised, especially in relation to their content in 58	
saturated fats, which has been the focus of major attentions because of the detrimental effect on 59	
serum lipids, a well-known major cardiovascular risk factor, and hormone dysregulation (i.e., 60	
effects on growth factors that may increase the risk of certain cancers) (Lin et al. 2018, Siri-Tarino 61	
et al. 2010, Touvier et al. 2015, YuPeng et al. 2015). Despite plenty of studies have been conducted 62	
on this matter, a comprehensive systematic evaluation of the evidence on the association between 63	
dairy products and human health might be useful to provide an overview with consistent and 64	
univocal methodology. Thus, in this study we aimed to investigate the level of evidence for the 65	
association between consumption of total dairy products, as well as individual selected dairy food 66	




In order to evaluate the level of evidence on consumption of major food sources of vitamin D, an 71	
umbrella review of existing prospective cohort studies was performed. A systematic search for 72	
research syntheses of different outcomes investigating the association with exposure of fish, dairy 73	
products, and egg intake was conducted in Medline and Embase electronic databases up to January 74	
2017. The search was independently performed by two authors (GG and JG) and any discrepancies 75	
were solved with discussion. Inclusion criterion was meta-analyses of prospective cohort studies or 76	
randomized controlled trials (RCTs) considering dairy product consumption as variable of exposure 77	
and any disease condition as outcome. Exclusion criteria were the following: RCTs exploring the 78	
relation between the aforementioned exposures and intermediary biomarkers of disease (i.e., blood 79	
lipids, blood pressure, etc.) or intermediary clinical conditions (i.e., variation in body weight/BMI, 80	










author and year of publication, outcome, number of studies included in the meta-analysis, study 86	
design of included studies (i.e., case-control/cross-sectional and prospective), total number of 87	
population exposed, number of cases, type of exposure, measure of exposure [including highest 88	
versus lowest (reference) category of exposure or dose-response incremental servings per day 89	
(linear)], effect sizes [risk ratio (RR), odds ratio (OR), or hazard ratio (HR)]. 90	
Data evaluation and evidence synthesis 91	
Whenever more than one meta-analysis was conducted on the same outcome, included the same 92	
study design, and the same type of population, concordance for the main outcome of interest, 93	
including direction and magnitude (overlapping confidence interval) of the association was 94	
evaluated. For further analyses, the most recent/exhaustive study was considered. The pooled 95	
analyses of the highest vs. the lowest (reference) category of exposure and dose-response analyses 96	
were evaluated. Direction, magnitude, heterogeneity (I2), and subgroup/stratified analyses for 97	
potential confounding factors were considered to have indication of level of evidence. Criteria used 98	
for evidence categorization were modified from the Joint WHO/FAO Expert Consultation 99	
(Paganoni and Schwarzschild 2017) as shown in Table 1. Briefly, the relation between exposure 100	
and outcomes was categorized as following: suggestive/limited/contrasting evidence, when there 101	
was availability of solely meta-analysis of case-control studies, limited prospective cohort studies 102	
included in meta-analyses (n <3), or evident contrasting results from meta-analyses with the same 103	
level of evidence; possible evidence, when there was availability of meta-analyses with lack of 104	
information on/significant heterogeneity (I2 >50%) or identification of potential confounding factors 105	
(i.e., different findings in subgroups); probable association, when there was availability of meta-106	
analyses of prospective cohort studies with no heterogeneity, no potential confounding factors 107	
identified, and eventual disagreement of results over time reasonably explained (and evidence of 108	
dose-response relation further investigated); convincing association, when there was concordance 109	
between meta-analyses of RCTs and observational studies. 110	
Results 111	
Study selection 112	
Out of 894 articles identified through the search strategy and a first selection based on title and 113	
abstract, 101 articles were investigated for further consideration: the exclusion list included 28 114	
articles because including meta-analyses of RCTs (n = 8), had different design (n = 15), different 115	
exposure (n = 2), or different outcomes (n = 3). The final selection of articles included 53 studies 116	






Bischoff-Ferrari et al. 2011, Boyd et al. 1993, Boyd et al. 2003, Caini et al. 2016, Chen et al. 2015, 118	
Chen et al. 2017, Chen et al. 2007, Chen et al. 2014, de Goede et al. 2015, de Goede et al. 2016, 119	
Dong et al. 2011, Elwood et al. 2004, Gao et al. 2013, Gao et al. 2005, Gijsbers et al. 2016, Guo et 120	
al. 2015, Hu et al. 2014, Huncharek et al. 2008, Huncharek et al. 2009, Jiang et al. 2014, Kim and 121	
Je 2016, Larsson et al. 2006, Li et al. 2016, Li et al. 2011, Liu et al. 2015, Lu et al. 2016, Mao et al. 122	
2011, Mullie et al. 2016, O'Sullivan et al. 2013, Pimpin et al. 2016, Qin et al. 2015, Qin et al. 2005, 123	
Qin et al. 2004, Qin et al. 2007, Ralston et al. 2012, Ralston et al. 2014, Soedamah-Muthu et al. 124	
2011, Soedamah-Muthu et al. 2012, Sun et al. 2014, Tian et al. 2014, Tong et al. 2011, Wang et al. 125	
2016, Wu et al. 2016, Wu and Sun 2016, Xu, Zhang, et al. 2015, Yang et al. 2016, Yu et al. 2016, 126	
Zang et al. 2015) on dairy product. 127	
 128	
Meta-analyses on dairy product consumption and health outcomes 129	
The characteristics and summary risk estimates for the highest versus the lowest category of total 130	
dairy, milk, cheese, butter, and yogurt on unique outcomes of non-overlapping meta-analyses 131	
including ³3 prospective cohort studies are presented in Figure 2, Figure 3, Figure 4, Figure 5, and 132	
Figure 6, respectively. The characteristics and summary risk estimates by dose of dairy product 133	
consumption evaluated in non-overlapping meta-analyses on total dairy (n = 7) (Alexander et al. 134	
2016, Aune et al. 2012, Aune et al. 2015, de Goede et al. 2016, Gijsbers et al. 2016, Soedamah-135	
Muthu et al. 2012, Zang et al. 2015), milk (n = 9) (Aune et al. 2012, Aune et al. 2015, Bischoff-136	
Ferrari et al. 2011, de Goede et al. 2016, Gijsbers et al. 2016, Jiang et al. 2014, Mullie et al. 2016, 137	
O'Sullivan et al. 2013, Xu, Zhang, et al. 2015), cheese (n = 6) (Aune et al. 2012, Aune et al. 2015, 138	
Chen et al. 2014, Gijsbers et al. 2016, Jiang et al. 2014, O'Sullivan et al. 2013), butter (n = 1) 139	
(Pimpin et al. 2016), and yogurt (n = 2) (Aune et al. 2015, Gijsbers et al. 2016) testing for linear 140	
association with unique outcomes are reported in Supplementary Table 1. Meta-analyses on total 141	
dairy consumption and stroke mortality, colorectal cancer, metabolic syndrome, elevated blood 142	
pressure, stroke, CVD, T2DM, and breast cancer reported a statistically significant association with 143	
reduced risk for the highest versus the lowest category of consumption, while those on prostate 144	
cancer and Parkinson’s disease reported a significant increased risk (Figure 2); meta-analyses on 145	
milk consumption showed significant decreased risk of cognitive disorders, metabolic syndrome, 146	
colon and colorectal cancer, and elevated blood pressure, while increased risk of prostate and 147	
Parkinson’s disease (Figure 3); meta-analyses on cheese consumption showed significant decreased 148	
risk of T2DM, CHD, CVD, and stroke, while increased risk of prostate cancer (Figure 4); meta-149	
analyses on butter showed no significant results (Figure 5); meta-analyses on yoghurt showed 150	






increasing consumption of total dairy was linearly associated with significant decreased risk of 152	
metabolic syndrome, hypertension, breast and colorectal cancers; milk with decreased risk of 153	
colorectal cancer and stroke; cheese with decreased risk of CHD; butter and yoghurt with decreased 154	
risk of T2DM (Supplementary Table 1). However, meta-analyses on stroke risk reported evidence 155	
of significant heterogeneity of results between studies. Furthermore, some studies showed potential 156	
confounding factors that may affect the level of evidence (Supplementary Table 2): total dairy 157	
consumption was associated with decreased risk of stroke (Hu et al. 2014), T2DM (Aune et al. 158	
2013), and breast cancer (Zang et al. 2015) only in women and studies conducted in the US, while 159	
increased risk of Parkinson’s disease was reported only in men (Jiang et al. 2014); total dairy and 160	
milk consumption were associated with increased risk of prostate cancer only in studies conducted 161	
in the US (Aune et al. 2015); milk was associated with decreased risk of colorectal cancer only in 162	
men and studies conducted in Europe and US (Aune et al. 2012); cheese was associated with 163	
decreased risk of CVD, CHD and stroke only in women and studies conducted in the US (Chen et 164	
al. 2017); cheese was associated with decreased risk of T2DM only in studies conducted in the US 165	
(Aune et al. 2013). Moreover, meta-analyses on total dairy consumption and T2DM risk, and milk 166	
and colorectal cancer risk showed non-significant associations when the analyses were restricted to 167	
studies adjusting for smoking status. Similarly, meta-analyses on total dairy consumption and 168	
prostate cancer showed non-significant associations when the analyses were restricted to studies 169	
adjusting for alcohol consumption. Among other potential confounding, fat content of dairy foods 170	
has been taken into account in several studies: only the analyses restricted to low-fat dairy showed 171	
significant decreased risk of breast cancer (RR = 0.85, 95% CI: 0.75, 0.96; I2 = 43%) (Zang et al. 172	
2015), CHD (RR = 0.90, 95% CI: 0.82, 0.98; I2 = 0%) (Alexander et al. 2016), elevated blood 173	
pressure (RR = 0.84, 95% CI: 0.74, 0.95; I2 = 38%) (Ralston et al. 2012) and hypertension (RR = 174	
0.96, 95% CI: 0.93, 0.99; I2 = 25%) (Soedamah-Muthu et al. 2012), stroke (RR = 0.90, 95% CI: 175	
0.83, 0.96; I2 = 0%) (Alexander et al. 2016), T2DM (RR = 0.83, 95% CI: 0.76, 0.90; I2 = 0%) 176	
(Aune et al. 2013), while no significant associations were reported for whole/full-fat dairy products. 177	
In contrast, the association between milk consumption and prostate cancer risk showed increased 178	
risk for consumption of low-fat milk (RR = 1.14, 95% CI: 1.05, 1.25; I2 = 51%) and decreased risk 179	
for consumption of whole milk (RR = 0.92, 95% CI: 0.85, 0.99; I2 = 0%) (Aune et al. 2015); 180	
similarly, an increased risk of ovarian cancer has been also detected for consumption of low-fat 181	
milk (RR = 1.35, 95% CI: 1.09, 1.68; I2 = 0%) (Larsson et al. 2006). 182	
 183	
The list and main findings of meta-analyses for outcomes with more than one meta-analysis showed 184	






yoghurt reported decreased risk of breast cancer; two meta-analyses showed decreased risk and null 186	
association of CVD for total dairy and milk consumption (Alexander et al. 2016, Elwood et al. 187	
2004); also a previous study on prostate cancer risk showed null results for total dairy, milk, and 188	
cheese consumption (Huncharek et al. 2008); in contrast, a previous study on stroke (ischaemic) 189	
showed decreased risk for milk consumption (Elwood et al. 2004). We did not detect any particular 190	
flaws or mistakes among meta-analyses and differences are ascribable to updated results. 191	
 192	
Summary of evidence 193	
A summary of variables investigated to assess the strength of the evidence relating dairy products 194	
consumption with various health outcomes is presented in Supplementary Table 4: the summary 195	
evidence is showed in Table 1. There is convincing evidence of association between total dairy 196	
consumption and decreased risk of colorectal cancer and hypertension, probable association with 197	
decreased risk of CVD, elevated blood pressure, and fatal stroke, and possible association with 198	
decreased risk of breast cancer, metabolic syndrome, stroke, and T2DM, while increased risk of 199	
prostate cancer and Parkinson’s disease. Among specific types of dairy foods, the strongest 200	
evidence (probable) for decreased risk of elevated blood pressure and metabolic syndrome and 201	
increased risk of Parkinson’s disease was associated with milk consumption, while cheese and 202	
butter consumption were associated with possible decreased risk of T2DM; other possible 203	
associations were found for milk and decreased risk of colorectal cancer and cognitive 204	
disorders/increased risk of prostate cancer, yoghurt and decreased risk of T2DM, cheese and 205	
decreased risk of CVD, CHD, and stroke. 206	
 207	
Discussion 208	
In this umbrella review, the existing evidence on dairy foods consumption and various health 209	
outcomes was investigated. Overall, the strongest evidence interested an association with decreased 210	
risk of cardiovascular-related diseases for higher consumption of total dairy foods compared to low; 211	
moreover, a decreased risk of colorectal cancer was also observed. Among the outcomes that 212	
showed potential confounding factors, type of dairy (low-fat vs. whole) may affect T2DM, elevated 213	
blood pressure/hypertension, breast, ovarian, and prostate cancer risk. Some concerns aroused 214	
concerning specific dairy foods, such as milk and cheese, and increased risk of prostate cancer and 215	
Parkinson’s disease, respectively. 216	
 217	
There is evidence that consumption of dairy foods may affect long-term cardio-metabolic health: 218	






(Sluijs et al. 2012). A possible explanation could be the potential effect toward blood pressure, but 220	
this association was significant in particular for milk, rather than other dairy foods. Some key 221	
components such as fats [including mono-unsaturated fatty acids (MUFA)] and proteins (including 222	
casein and whey protein) may play a role in cardiovascular prevention. Among proteins, whey 223	
protein has been associated with several metabolic benefits, including improved blood pressure 224	
control, serum lipid profile, body composition, insulin sensitivity and glucose regulation 225	
(Bjornshave and Hermansen 2014). Dairy products are also a rich source of calcium: there is 226	
evidence associating dietary calcium intake with several metabolic benefits, including regulation of 227	
serum lipids, weight maintenance and body composition, blood pressure regulation, and insulin 228	
sensitivity and glucose metabolism (Muldowney and Kiely 2011). Together with calcium, also 229	
vitamin D (and its active form 1,25-dihydroxycholecalciferol) has been shown to play a role in 230	
shaping body composition through regulation of energy metabolism by controlling the expression 231	
of uncoupling proteins, down-regulating leptin, the appetite regulating hormone, and through 232	
inhibition of adipogenic transcription factors and lipid accumulation during adipocyte 233	
differentiation (Abbas 2016). Furthermore, there is mechanistic evidence that vitamin D might 234	
affect blood pressure through regulation of the rennin-angiotensin-aldosterone system and 235	
suppression of parathyroid hormone, which are known mechanisms regulating blood pressure (Min 236	
2013). Finally, its effect in regulating parathyroid hormone and intracellular calcium has been also 237	
associated with modulation of insulin production and release through effects in pancreatic beta cells 238	
and adipocytes (Palomer et al. 2008). An indirect potential effect of vitamin D that may decrease 239	
the metabolic risk is its antioxidant action (Pannu et al. 2016) through inflammatory cytokine gene 240	
expression and secretion from adipocytes and macrophages (Sun and Zemel 2008), regulation of 241	
nuclear factor kappa-light-chain-enhancer of activated B cells inhibition, and increased production 242	
of endothelial prostacicline, a prostaglandin with anti-inflammatory activities (Okajima and Harada 243	
2006). 244	
 245	
The risk of another outcome significantly decreased by consumption of dairy foods was colorectal 246	
cancer (especially colon). This finding is in line with previous literature based on a pooled analysis 247	
of ten prospective cohorts (Cho et al. 2004). Protection toward cancer may depend on the effect of 248	
vitamin D and its influence on calcium metabolism. In fact, 1,25-dihydroxycholecalciferol directly 249	
regulates multiple signaling pathways involved in cell proliferation, apoptosis, differentiation, 250	
inflammation, invasion, angiogenesis and metastasis (Feldman et al. 2014). Moreover, intracellular 251	
calcium has been shown to influence cell growth and apoptosis of cells (Whitfield 2009) and it has 252	






cells (Bernstein et al. 2005). Another proposed mechanism of protection against colorectal cancer 254	
associated with dairy consumption is modulation of gut microbiota (Davoodi et al. 2013): in fact, 255	
bacterial translocation and consequent increase of inflammation and production of bacterial 256	
genotoxins have been hypothesized to be potential risk factors for colorectal cancer initiation and 257	
development by inducing DNA damage and producing metabolites that can active carcinogens 258	
(Riaz Rajoka et al. 2017). In this context, consumption of dairy foods may have an impact on the 259	
balance between microbial production of health-beneficial metabolites, such as butyrate, and 260	
potentially tumorigenic metabolites, such as secondary bile acids (Yang and Yu 2018). 261	
 262	
Regarding potentially detrimental associations found in this study, there is evidence of increased 263	
risk of Parkinson’s disease and prostate cancer related to consumption of milk and cheese, 264	
respectively. Regarding Parkinson’s disease, it has been shown that milk proteins (casein and 265	
lactalbumin) reduce serum urate levels, which has been hypothesized to be protective against 266	
Parkinson’s disease (Crotty et al. 2017, Paganoni and Schwarzschild 2017). Another potential 267	
explanation is related to the content in pesticides of dairy foods: specifically, it has been 268	
hypothesized that a genetic susceptibility either in metabolism, elimination and transport of 269	
pesticides or in the extent of mitochondrial dysfunction, oxidative stress and neuronal loss may play 270	
a role in Parkinson’s disease risk (Dardiotis et al. 2013). However, both potential mechanisms are 271	
rather weak and merely speculative. Thus, a stronger rationale is needed to explain such association. 272	
Regarding prostate cancer risk, earlier hypotheses speculated on the potential role of calcium as risk 273	
factor, but such hypothesis is jeopardized by the results of a subgroup analysis provided in one of 274	
the meta-analyses reviewed showing that there was no association with intake of non-dairy calcium 275	
(Aune et al. 2015). Alternatively, dairy products may play a role toward prostate cancer risk via the 276	
insulin-like growth factor (IGF) pathway (including IGF-I, IGF-II, IGFBP-1, IGFBP-2, and IGFBP-277	
3), which has been related to cell proliferation promotion and apoptosis inhibition (Harrison et al. 278	
2017) and, definitely, an increased risk of prostate cancer (Roddam et al. 2008). All hypotheses 279	
presented are mere speculation and further research is needed to provide a stronger rationale for the 280	
retrieved results. 281	
 282	
Results generated from meta-analyses are promising, but some concerns regarding the consistence 283	
of such evidence still remains. Specifically, results on total dairy products and metabolic syndrome, 284	
stroke, breast cancer and T2DM (all outcomes somehow related to the potential effects of dairy on 285	
metabolic pathways) are affected by potential confounding related to sex and geographical location 286	






individuals exposed to dairy consumption have not yet been entirely identified, although it may be 288	
hypothesized that sex hormones might be involved. In pre-menopausal women, estrogens levels are 289	
generally protecting against cardiovascular and other diseases compared to men of the same age; 290	
dairy consumption may somehow interact with hormonal levels and affect the overall risk 291	
(Mirmiran et al. 2016).  292	
 293	
Regarding geographical location, there is no specific hypothesis previously formulated and any 294	
potential reason is merely speculative. European and US milk undergoes different processing 295	
methods: despite nearly all commercial milk is pasteurized (meaning it undergoes extreme heat in 296	
order to kill illness-causing bacteria), the US and Canada use the high-temperature short-time 297	
pasteurization (HTST), which is cheaper and more efficient but milk has a shorter shelf life (around 298	
seven to 10 days) and must be refrigerated; while Europe uses ultra-heat-treated pasteurization 299	
(UHT), which heats the milk to an even higher temperature than HTST and lead to a longer shelf 300	
life of the milk. Some differences have been accounted between the two methods (i.e., total viable 301	
counts are lower in UHT compared to HTST milk (Lorenzen et al. 2011); the denatured proteins in 302	
UHT processing may be more accessible to the digestive enzymes than after HTST (Tunick et al. 303	
2016)), but, definitely, there is no data supporting any substantial difference in different effects on 304	
health of these two pasteurization techniques; however, we cannot exclude that, if any, they might 305	
depend on that. Despite it has been reported that dairy products has generally low content of 306	
phthalates, some differences between countries might occur (Serrano et al. 2014). Another 307	
difference between US and European milk relies on the type of casein (the main milk protein): 308	
digestion of bovine A1 beta-casein (particularly present in Europe), but not the alternative A2 beta-309	
casein, releases beta-casomorphin-7, which activates µ-opioid receptors expressed throughout the 310	
gastrointestinal tract resulting in increased gastrointestinal transit time, production of dipeptidyl 311	
peptidase-4 and the inflammatory marker myeloperoxidase (Pal et al. 2015). Finally, genetic 312	
variants (i.e., mutations in the lactase gene resulting in lactase persistence) have shown to 313	
potentially play a role between dairy consumption and cardio-metabolic diseases, certain types of 314	
cancer and bone health, as well as lipid metabolism, hormone receptor function, and vitamin D 315	
receptor function, but current research has produced mixed results and the potential for differential 316	
sensitivity between genotypes to the health effects of dairy food intake has to be further investigated 317	
(Comerford and Pasin 2017). 318	
 319	
Among other potential confounding/modifying/mediating factors, the fat content of dairy has been 320	






products, especially butter, has been under investigation due to the high content in saturated fats. 322	
However, recent meta-analyses of prospective cohort studies showed a relatively small impact of 323	
saturated fats on CVD risk and other outcomes (Chowdhury et al. 2014, de Souza et al. 2015). 324	
Equally, overall evidence of dietary fat intake and cancer risk is weak (Xu, Han, et al. 2015). 325	
Moreover, there is no consistency in the direction of the association stratified by fat content of 326	
dairy, as low-fat dairy consumption was associated with both decreased risk of several cardio-327	
metabolic conditions but also increased risk of prostate and ovarian cancers, while high-fat dairy 328	
consumption was associated with decreased risk of prostate cancer. Finally, the retrieved 329	
association with decreased risk of CVD is inconsistent with the lack of association with risk of 330	
CVD mortality (it would be expected that the associations would agree on the same direction of the 331	
risk). These contrasting results need to be further addressed with ad hoc investigations aiming to 332	
better define the role of total dietary fats in relation to dairy foods. 333	
 334	
Regarding other limitations to be taken into account when interpreting the results presented in this 335	
umbrella review, it must be noted that grouping individual foods in major food groups is 336	
comfortable and perhaps necessary for certain analyses interesting population studies, but there 337	
might be considerable differences in nutrients and compounds content among different type of dairy 338	
products. Other potential confounding factors, such as physical activity, smoking, alcohol, or more 339	
specifically related to the outcomes investigated (i.e., prostate specific antigen testing) may have 340	
also been associated to dairy product consumption. Regarding meta-analyses included, publication 341	
bias or small study effects may lead to exaggerated summary estimates. Regarding cohort studies 342	
included in the meta-analyses, measurement errors in the dietary assessment is another potential 343	
limitation to be taken into account. 344	
 345	
In conclusions, consumption of dairy products showed a probable association with CVD and xxx, 346	
despite consistence of results is partially debatable. 347	
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Table 1. Level of evidence for the association between dairy (total and individual foods) consumption and health outcomes. 594	
Level of 
evidence* 
Criteria§ Total dairy Milk Yogurt Cheese Butter 
Convincing Meta-analyses of prospective 
cohort studies with evidence of 
dose-response relation, no 
heterogeneity, no potential 
confounding factors identified, 
and eventual disagreement of 
results over time reasonably 
explained [otherwise declassed 
as possible]. 
Association with 
decreased risk of cancer 
(colorectum), 
hypertension.  
None. None. Association with 
increased risk of 
cancer (prostate). 
None. 
Probable Meta-analyses of prospective 
cohort studies with no 
heterogeneity, no potential 
confounding factors identified, 
and eventual disagreement of 
results over time reasonably 
explained [otherwise declassed 
as possible]. 
None. None. None. None. None. 
Possible Meta-analysis of prospective 
cohort studies with no 
heterogeneity and lack of 
information on potential 
confounding factors. 
Association with 
decreased risk of CVD 
(any), elevated blood 
pressure, stroke (fatal). 
• Association with 





• Association with 
increased risk of 
Parkinson’s 
disease. 
None. Association with 




decreased risk of 
T2DM. 
 
Limited Meta-analysis of prospective 
cohort studies with presence of 
significant heterogeneity (I2 
>50%) or identification of 
potential confounding factors 










• Association with 





• Association with 
increased risk of 
Association with 




decreased risk of 
CHD (any)#, CVD 














Insufficient Meta-analysis of case-control 
studies, limited prospective 
cohort studies included in 
meta-analyses (n <3), or 
evident contrasting results 
from meta-analyses with the 
same level of evidence. 
• Association 
with decreased 










increased odds of cancer 
(diffuse large B-cell 
lymphoma). 
None. None. None. 
No evidence Non-significant results from 
meta-analyses of either 
prospective or case-control 
studies. 
No association with risk 





lung, NHL, stomach), 





No association with risk 







stomach), CHD (any)#, 




fatal, total), kidney stones, 
T2DM. 
No association with 
risk of cancer (breast, 
diffuse large B-cell 
lymphoma, ovarian, 






No association with 











CVD), elevated blood 
pressure, Parkinson’s 
disease. 
No association with 
risk of cancer 
(bladder), CHD (any), 
CVD (any), mortality 
(all-cause), stroke 
(total). 
*all the associations should be biologically plausible; potential confounding factors should be taken into account. 
§ modified from the Joint WHO/FAO Expert Consultation 















Figure 2. Summary results from meta-analyses of prospective cohort studies on total dairy 599	







Figure 3. Summary results from meta-analyses of prospective cohort studies on milk consumption 602	









Figure 4. Summary results from meta-analyses of prospective cohort studies on cheese consumption 607	









Figure 5. Summary results from meta-analyses of prospective cohort studies on butter consumption 612	







Figure 6. Summary results from meta-analyses of prospective cohort studies on yogurt consumption 615	








Supplementary Table 1. Summary results from meta-analyses investigating continuous linear 619	
exposure to dairy (total and individual foods) consumption and health outcomes. NA, not available. 620	
 621	
Supplementary Table 2. Significance and direction of results from selected meta-analyses on dairy 622	
(total and individual foods) consumption and health outcomes. “S” denotes significant results; NS 623	
denotes non-significant results; symbols “+” and “-“ denote direction of the association. NA, not 624	
available. 625	
 626	
Supplementary Table 3. Results of meta-analyses (highest vs. lowest category of exposure) on dairy 627	
(total and individual foods) consumption and health outcomes with limited number of prospective 628	
cohort studies (<3) or case-control studies (either alone or mixed with prospective cohort studies). 629	
 630	
Supplementary Table 4. Variables investigated to address the strength of evidence from selected 631	
meta-analyses on dairy (total and individual foods) consumption and health outcomes. 632	
